Abstract:
A pharmaceutical composition of preventing and treating cadmium poisoning related diseases is provided to increase cell viability about cadmium toxicity and expression of MT gene, to suppress active oxygen using long-lived platycodon grandiflorum tablet fraction material as active ingredient. A pharmaceutical composition of preventing and treating cadmium poisoning related diseases comprises long-lived platycodon grandiflorum tablet fraction material as active ingredient. The tablet fraction material is a crude saponin tablet fraction material obtained by producing platycodon extract through ion-exchange resin. The cadmium poisoning related disease is lithonephria, itai-itai disease, cancer or neurodegenerative disease. A health food of preventing and treating cadmium poisoning related diseases comprises long-lived platycodon grandiflorum tablet fraction material as active ingredient. The health food is refinement, capsule, and pilule or liquor.
Abstract:
본 발명은 세포독성 개선 및 간손상 억제활성을 갖는 독활 추출물을 함유하는 간질환의 예방 및 치료용 조성물에 관한 것으로, 독활 추출물을 함유하는 본 발명의 조성물은 tBHP(tert butyl hydroperoxide) 및 사염화 탄소로 유발한 간세포에서 GSH(glutathione) 함량이 회복되고, 활성산소(ROS) 생성 및 지질과산화 정도가 감소하며, 유독성 화학물질 대사체의 체외 배출을 촉진하는 항산화 효소(GST, HO-1, NQO1)의 활성을 증가시켜 세포 독성 개선효과 및 ALT(alanine amino transferase) 및 AST(aspartate alanine amino transferase) 효소활성의 감소에 의한 간 손상 보호 효과를 확인하여, 간질환 예방 및 치료용 조성물로 유용하게 이용될 수 있다. 독활, 간질환
Abstract:
A pharmaceutical composition for preventing and treating the liver disease, and a health food are provided to inhibit the hepatotoxicity by increasing the activity of an antioxidizing enzyme. A pharmaceutical composition for preventing and treating the liver disease contains an extract of Aralia continentalis Kitagawa as an active ingredient. Preferably the extract of Aralia continentalis Kitagawa is the extract soluble in the solvent selected from water, a C1-C4 low molecular weight alcohol and their mixture solvent.